by Halley Porter | Feb 6, 2023 | Ezricare
PADUCAH — Incidents of serious eye infections, permanent injury, blindness, and in at least one case — death — have been linked to the now recalled EzriCare and Delsam Pharma Artificial Tears. According to the Center for Disease Control and Prevention, the drops...
by Halley Porter | Feb 1, 2023 | Ezricare
The Centers for Disease Control and Prevention (CDC) has warned consumers to stop using “EzriCare Artificial Tears” due to a multistate cluster of eye infections linked to Pseudomonas Aeruginosa, an antibiotic resistant bacteria which has resulted in one death and...
by awkolaw2 | May 6, 2018 | Defective Drugs
FDA was worried Nuplazid was risky but approved its use anyway Nuplazid (pimavanserin) is an anti-psychotic drug manufactured by Acadia Pharmaceuticals that is approved for use in the treatment of debilitating and frightening psychosis in Parkinson’s patients. The...
